Hong Tang Biography Dr. Hong Tang is Chief Medical Officer, and co-founder of OnQuality Pharmaceuticals. Hong is a Board-certified internal medicine physician with more than 15 years’ experience in both drug development and medical affairs, and conducted all phases of clinical trials. She served as VP, Executive Medical Director, Medical Director, and Medical Officer in Dendreon, Juno, Astellas, BMS and NIH. OnQuality Pharmaceuticals is designing targeted cancer supportive care treatments aimed at preventing and treating the intolerable side effects caused by specific cancer drugs. Their missi ..read more

George Chen Biography George Chen, MD MBA, is an oncologist by training with a successful track record in the world of global pharmaceutical companies.  Prior to founding D3 Bio, Dr. Chen held senior global positions in research, drug development and management at leading institutions, such as the National Institutes of Health, and multinational pharmaceutical companies, such as Eli Lilly, GlaxoSmithKline, Johnson & Johnson, BeiGene, and Astra Zeneca.  At these organizations he led development and regulatory registrations of blockbuster drugs into the U.S. and Chinese markets, di ..read more

Dr. Bing Yuan is an entrepreneur and a seasoned business executive in business development and licensing (BD&L), marketing and new product strategy. He has made significant contributions to 13 approved global oncology drugs at various stages of product life cycle, including blockbusters such as Keytruda and Glivec. Before founding OnCusp, he was Chief Strategy and Business Officer at CStone Pharmaceuticals. As a senior executive from the beginning, he helped to build the company from scratch to successful IPO and a fully integrated biopharma. At CStone, he established and managed over 10 d ..read more

Shawn Xiang Biography Dr. Xiang is the CEO of Rarestone Group, a company building the first rare disease ecosystem in China. Dr. Xiang has more than 15 years of leadership experience in pharmaceutical and medical device industries. Prior to RareStone, Shawn was the General Manager of Greater China and Emerging Asia Region at Abbott Diabetes Care, where he led his team and successfully launched FreeStyle Libre in China, Korea and Southeast Asia markets and achieved hyper-growth consecutively over the years. Shawn also led his team to build an ecosystem for patients living with Type 1 Diabetes ..read more

Brad Loncar Biography Brad Loncar is a biotechnology industry investor and CEO of Loncar Investments. He is the creator of two Nasdaq-listed biotech focused exchange-traded funds. Brad previously worked in the financial services industry at Franklin Templeton Investments where he was a member of the Management Training Program, and was appointed to serve in a Senior Advisor role at the U.S. Department of the Treasury. He currently writes biotechnology commentary at www.LoncarBlog.com, Nasdaq.com, and contributes opinion pieces to Endpoints News. He’s also the co-host of Biotech Clubhouse, whic ..read more

Welcome to Season 2 of Behind Biotech. This season, we’re lucky to have a special guest host with us, Patrick Jiang, an MBA candidate at Harvard Business School, and the Co-Founder and CBO of InGel Therapeutics. This season, we’re taking a behind the scenes look at the booming China biotech scene. We’re profiling a series of founders, executives and investors who are hoping to build the next “Genentech” in Asia . In introducing this season, we also want to impart an important message to our listeners: In an increasingly global society where politics are unavoidable, we want you to remember tha ..read more

Dr. Ricky Barrett Biography Ricky is a post-doctoral fellow at the University of Pennsylvania, where he works in the lab of Dr. Ellen Pure to better understand heterogeneity in the tumor stroma and how different cell types interact to influence tumor immune response with the direct goal of developing new stromal based therapeutics. He did his PhD in Biomedical sciences at the University of Central Florida, where he studied the role of innate immunity in metabolic disease. Ricky is currently managing collaborative projects with pharmaceutical companies in academic/industry partnerships. Moreove ..read more

Hyun (Michel) Koo, DDS, MS, PhD obtained his DDS from The Sao Paulo State University, Brazil, and later obtained his MS in Food Engineering and PhD in Oral Biology from The University of Campinas, Brazil as well as the University of Rochester Medical Center. Michel joined the faculty at Penn in 2013, where he has led interdisciplinary research integrating oral, biomedical and engineering sciences, culminating with the launch of the Center for Innovation & Precision Dentistry (CiPD), uniting the dental and engineering schools at Penn. Michel has been recognized as an outstanding leader for ..read more

Aimee Payne MD, PhD is a Professor of Dermatology and Director of the Clinical Autoimmunity Center of Excellence at the University of Pennsylvania. She received her MD/PhD from Washington University School of Medicine, followed by dermatology residency and fellowship training at the University of Pennsylvania. Her clinical practice specializes in autoimmune blistering diseases including pemphigus and pemphigoid.  Her laboratory research has investigated B cell repertoires in pemphigus in order to develop precision medicine therapies for disease.  At Penn, Dr. Payne also serves as Cor ..read more

Anne Chew, PhD, is the Executive Deputy Director for the University of Pennsylvania (UPenn) Center for Cellular Immunotherapies (CCI) and one of the co-founders of Tmunity. She is responsible for overall strategic and operational leadership of all CCI-sponsored research programs and translational development initiatives in cell and gene therapy. Since 2006, she has served in senior regulatory, clinical operations, manufacturing operations and translational sciences roles at UPenn. Dr. Chew has more than 15 years of translational research and development experience in both industry and academic ..read more